These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 18028545)
1. Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein. Costin JM; Rausch JM; Garry RF; Wimley WC Virol J; 2007 Nov; 4():123. PubMed ID: 18028545 [TBL] [Abstract][Full Text] [Related]
2. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation. Kalia V; Sarkar S; Gupta P; Montelaro RC J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139 [TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinants. Yang P; Ai LS; Huang SC; Li HF; Chan WE; Chang CW; Ko CY; Chen SS J Virol; 2010 Jan; 84(1):59-75. PubMed ID: 19793805 [TBL] [Abstract][Full Text] [Related]
4. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41. Chen SS; Lee SF; Wang CT J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825 [TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. Comardelle AM; Norris CH; Plymale DR; Gatti PJ; Choi B; Fermin CD; Haislip AM; Tencza SB; Mietzner TA; Montelaro RC; Garry RF AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1525-32. PubMed ID: 9390752 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail. Durham ND; Chen BK J Virol; 2015 Sep; 89(18):9324-37. PubMed ID: 26136566 [TBL] [Abstract][Full Text] [Related]
8. Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain. Newman JT; Sturgeon TJ; Gupta P; Montelaro RC Virology; 2007 Oct; 367(1):102-16. PubMed ID: 17582453 [TBL] [Abstract][Full Text] [Related]
9. Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41. Kuhlmann AS; Steckbeck JD; Sturgeon TJ; Craigo JK; Montelaro RC J Biol Chem; 2014 Mar; 289(11):7630-40. PubMed ID: 24497632 [TBL] [Abstract][Full Text] [Related]
10. Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein. Tencza SB; Miller MA; Islam K; Mietzner TA; Montelaro RC J Virol; 1995 Aug; 69(8):5199-202. PubMed ID: 7609094 [TBL] [Abstract][Full Text] [Related]
11. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors. Zhu Y; Ding X; Yu D; Chong H; He Y J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells. Sung JH; Shin SA; Park HK; Montelaro RC; Chong YH J Neurovirol; 2001 Oct; 7(5):454-65. PubMed ID: 11582518 [TBL] [Abstract][Full Text] [Related]
13. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Miller MA; Cloyd MW; Liebmann J; Rinaldo CR; Islam KR; Wang SZ; Mietzner TA; Montelaro RC Virology; 1993 Sep; 196(1):89-100. PubMed ID: 8356808 [TBL] [Abstract][Full Text] [Related]
14. Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication. Steckbeck JD; Craigo JK; Barnes CO; Montelaro RC J Biol Chem; 2011 Aug; 286(31):27156-66. PubMed ID: 21659530 [TBL] [Abstract][Full Text] [Related]
15. Effect of point mutations in the N terminus of the lentivirus lytic peptide-1 sequence of human immunodeficiency virus type 1 transmembrane protein gp41 on Env stability. Lee SF; Ko CY; Wang CT; Chen SS J Biol Chem; 2002 May; 277(18):15363-75. PubMed ID: 11859090 [TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41. Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393 [TBL] [Abstract][Full Text] [Related]
17. Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission. Ramakrishnan R; Mehta R; Sundaravaradan V; Davis T; Ahmad N Retrovirology; 2006 Jul; 3():42. PubMed ID: 16820061 [TBL] [Abstract][Full Text] [Related]
18. Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein. Beary TP; Tencza SB; Mietzner TA; Montelaro RC J Pept Res; 1998 Jan; 51(1):75-9. PubMed ID: 9495594 [TBL] [Abstract][Full Text] [Related]
19. Role of lentiviral lytic polypeptide I (LLP-I) in the selective cytotoxicity of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1-producing cells. Kubota S; Zhang H; Kitahara S; Pomerantz RJ Antivir Chem Chemother; 1999 May; 10(3):121-7. PubMed ID: 10431611 [TBL] [Abstract][Full Text] [Related]